POCNPOCN Facebook ad: “Review metabolic profile”
Ran for 27 days, from April 24 to May 21, 2026, the last day Crush saw it.
Run by POCN on Instagram. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1474854084667401
- Platforms
- Instagram and Threads
- Relaunches
- 0
Ad text
Please see full Prescribing Information, including Boxed Warning, for AUSTEDO XR® (deutetrabenazine) extended-release tablets at @austedopi. What might treatment with AUSTEDO XR mean for your patients taking concomitant medications?
Where the ad sends people
go.pointofcarenetwork.com
Review metabolic profile
As you know, it is important to consider potential drug-drug interactions when choosing a VMAT2 inhibitor for patients with TD.
Learn more: go.pointofcarenetwork.com(opens in a new tab)
